Please assess the completion status of the following clinical trial:

Trial Title: Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Hodgkin's lymphoma (histologically proven)~* Clinical stage IIB (with risk factors bulky mediastinal mass and/or extranodal involvement), III, or IV~* No prior antitumor therapy~* Age 60 to 75 years~* WHO performance status 0-2~* Normal pulmonary function~* Written informed consent~Exclusion Criteria:~* The following histologies are excluded: lymphocyte predominant HD~* Leukocytes \< 2,500/microL~* Platelets \< 100,000/microL

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).